In addition to concerns related to diminished protective immunity in children with T1D, NOD mouse studies show that anti-CD20 antibody is unable to prevent late-stage diabetes (after insulin autoantibodies are present), due in part to the downregulation of B cell CD20 expression in the pancreatic islets [159]. This evidence concerns the gene INS and type 1 diabetes mellitus.